Inhibiting Nrf2 in cancer cells leads to decreased expression of NADPH Quinone Dehydrogenase 1 (NQO1), HO1, and ferritin heavy chain (FTH1), which promotes ferroptosis [140]. The gene discussed is NFE2L2; the disease is cancer.